Literature DB >> 15063914

Training rural practitioners to use buprenorphine; using The Change Book to facilitate technology transfer.

Dennis McCarty1, Traci Rieckmann, Carla Green, Steve Gallon, Jeff Knudsen.   

Abstract

The Opiate Medication Initiative for Rural Oregon Residents trained physicians and counselors in Central and Southwestern Oregon to use buprenorphine and develop service models that supported patient participation in drug abuse counseling. The Change Book from Addiction Technology Transfer Centers was used to structure the change process. Fifty-one individuals (17 physicians, 4 pharmacists, 2 nurse practitioners, and 28 drug abuse counselors and administrators) from seven counties completed the training and contributed to the development of community treatment protocols. A pre-post measure of attitudes and beliefs toward the use of buprenorphine suggested significant improvements in attitude after training, especially among counselors. Eight months after training, 10 of 17 physicians trained had received waivers to use buprenorphine and 29 patients were in treatment with six of the physicians. The Change Book facilitated development of county change teams and structured the planning efforts. The initiative also demonstrated the potential to concurrently train physicians, pharmacists, and counselors on the use of buprenorphine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063914     DOI: 10.1016/S0740-5472(03)00247-2

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  15 in total

1.  The adoption of alcohol pharmacotherapies in the Clinical Trials Network: the influence of research network participation.

Authors:  Amanda J Abraham; Hannah K Knudsen; Tanja C Rothrauff; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2010-02-01

2.  Using organizational assessment as a tool for program change.

Authors:  Katherine Ortega Courtney; George W Joe; Grace A Rowan-Szal; D Dwayne Simpson
Journal:  J Subst Abuse Treat       Date:  2007-04-12

3.  Organizational Readiness for Change and opinions toward treatment innovations.

Authors:  Bret E Fuller; Traci Rieckmann; Edward V Nunes; Michael Miller; Cynthia Arfken; Eldon Edmundson; Dennis McCarty
Journal:  J Subst Abuse Treat       Date:  2007-04-16

4.  The Place of Adoption in the NIDA Clinical Trials Network.

Authors:  Martha A Jessup; Joseph Guydish; Sarah Turcotte Manser; Barbara Tajima
Journal:  J Drug Issues       Date:  2008

5.  A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment.

Authors:  Traci R Rieckmann; Anne E Kovas; Bentson H McFarland; Amanda J Abraham
Journal:  J Subst Abuse Treat       Date:  2011-08-06

6.  National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.

Authors:  Christopher M Jones; Melinda Campopiano; Grant Baldwin; Elinore McCance-Katz
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

7.  Barriers to primary care physicians prescribing buprenorphine.

Authors:  Eliza Hutchinson; Mary Catlin; C Holly A Andrilla; Laura-Mae Baldwin; Roger A Rosenblatt
Journal:  Ann Fam Med       Date:  2014 Mar-Apr       Impact factor: 5.166

8.  Clinician attitudes, social norms and intentions to use a computer-assisted intervention.

Authors:  Allison L Buti; Danielle Eakins; Holly Fussell; Lynn E Kunkel; Aisha Kudura; Dennis McCarty
Journal:  J Subst Abuse Treat       Date:  2012-09-27

Review 9.  Update on Barriers to Pharmacotherapy for Opioid Use Disorders.

Authors:  Anjalee Sharma; Sharon M Kelly; Shannon Gwin Mitchell; Jan Gryczynski; Kevin E O'Grady; Robert P Schwartz
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

10.  Buprenorphine Prescribing Availability in a Sample of Ohio Specialty Treatment Organizations.

Authors:  Todd Molfenter; Carol Sherbeck; Mark Zehner; Sandy Starr
Journal:  J Addict Behav Ther Rehabil       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.